Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

Sun, Yu, Campisi, Judith, Higano, Celestia, Beer, Tomasz M, Porter, Peggy, Coleman, Ilsa, True, Lawrence, Nelson, Peter S·2012·Nature Medicine

Cited by (791)

Items 401–500 of 791

  1. BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression
    Xiaohui Ling, Zhi‐Yun Chen, Hongwei Luo, Zezhen Liu, Yingke Liang, GUAN-XING CHEN, Fu-neng Jiang, Weide Zhong · 2016 · Oncology Letters
  2. Esterase-Responsive Polypeptide Vesicles as Fast-Response and Sustained-Release Nanocompartments for Fibroblast-Exempt Drug Delivery
    Weihua Duan, Sifan Ji, Yu Min Guan, Xueluer Mu, Sha Fang, Ying Lü, Xianfeng Zhou, Jing Sun, Zhibo Li · 2020 · Biomacromolecules
  3. The Roles of Secreted Wnt Ligands in Cancer
    Johannes Werner, Kim E. Boonekamp, Tianzuo Zhan, Michael Boutros · 2023 · International Journal of Molecular Sciences
  4. Does the microenvironment influence the cell types of origin for prostate cancer?
    Andrew S. Goldstein, Owen N. Witte · 2013 · Genes & Development
  5. Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression
    Haoran Chen, Su-Ping Fang, Xudong Zhu, Hao Liu · 2024 · Frontiers in Cell and Developmental Biology
  6. Stress responses in stromal cells and tumor homeostasis
    Ilio Vitale, Gwenola Manic, Claudia Galassi, Lorenzo Galluzzi · 2019 · Pharmacology & Therapeutics
  7. The Role of STAT1 for Crosstalk between Fibroblasts and Colon Cancer Cells
    Pawan Kaler, Benjamin Yaw Owusu, Leonard H. Augenlicht, Lidija Klampfer · 2014 · Frontiers in Oncology
  8. Computational Reconstruction of NFκB Pathway Interaction Mechanisms during Prostate Cancer
    Daniela Börnigen, Svitlana Tyekucheva, Xiaodong Wang, Jennifer R. Rider, Gwo‐Shu Mary Lee, Lorelei Ann Mucci, Christopher J. Sweeney, Curtis Huttenhower · 2016 · PLoS Computational Biology
  9. SPIN90 Depletion and Microtubule Acetylation Mediate Stromal Fibroblast Activation in Breast Cancer Progression
    Eunae You, Yun Hyun Huh, Ahreum Kwon, Sohee Kim, In Hee Chae, Ok-Jun Lee, Je-Hwang Ryu, Min Ho Park, Ga‐Eon Kim, Ji Shin Lee et al. · 2017 · Cancer Research
  10. WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma
    Dario Zimmerli, Virginia Cecconi, Tomáš Valenta, George Hausmann, Claudio Cantù, Gaetana Restivo, Jürg Hafner, Konrad Basler, Maries F. van den Broek · 2018 · Oncogene
  11. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP)
    Nicolas Malaquin, Véronique Tu, Françis Rodier · 2018 · Methods in molecular biology
  12. Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib
    Zhou Zhu, Nicholas C. Turner, Sherene Loi, Fabrice André, Miguel Martín, Veronique C Dieras, Karen A. Gelmon, Nadia Harbeck, Cathy Zhang, Joan Q. Cao et al. · 2022 · npj Precision Oncology
  13. Nanomedicine Strategies for Targeting Tumor Stroma
    Mei‐Chi Su, Susheel Kumar Nethi, Pavan Kumar Dhanyamraju, Swayam Prabha · 2023 · Cancers
  14. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer
    Joakin O. Mori, Isra Elhussin, W. Brennen, M. Graham, Tamara L. Lotan, Clayton C. Yates, A. D. De Marzo, S. Denmeade, S. Yegnasubramanian, William G. Nelson et al. · 2023 · Nature reviews. Urology
  15. Priming cancer cells for drug resistance: role of the fibroblast niche
    Wei Bin Fang, Min Yao, Nikki Cheng · 2014 · Frontiers in Biology
  16. Non‐autonomous overgrowth by oncogenic niche cells: Cellular cooperation and competition in tumorigenesis
    Masato Enomoto, John P. Vaughen, Tatsushi Igaki · 2015 · Cancer Science
  17. UVB-irradiated apoptotic cells induce accelerated growth of co-implanted viable tumor cells in immune competent mice
    Ricardo A. Chaurio, Christina Janko, Christine Schorn, Christian Maueröder, Rostyslav O. Bilyy, Udo S. Gaipl, Georg Andreas Schett, Christian Berens, Benjamin Frey, Luis Enrique Munoz · 2012 · Autoimmunity
  18. Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy
    Linda Johnson, Douglas K. Price, William Douglas Figg · 2013 · Cancer Biology & Therapy
  19. Killing Me Softly—Future Challenges in Apoptosis Research
    Mike‐Andrew Westhoff, Oliver Brühl, Lisa Nonnenmacher, Georg Karpel‐Massler, Klaus‐Michael Debatin · 2014 · International Journal of Molecular Sciences
  20. Differential drug responses of circulating tumor cells within patient blood
    Andrew D. Hughes, Jocelyn R. Marshall, Eric Keller, John D. Powderly, Bryan T. Greene, Michael R. King · 2013 · Cancer Letters
  21. At the crossroads of cancer stem cells and targeted therapy resistance
    Anbang Wang, Le Qu, Linhui Wang · 2016 · Cancer Letters
  22. Reversal of docetaxel resistance in prostate cancer by Notch signaling inhibition
    Shi Qiu, Linghui Deng, Yige Bao, Kun Jin, Xiang Tu, Jiakun Li, Xinyang Liao, Zhenhua Liu, Lu Yang, Qiang Wei · 2018 · Anti-Cancer Drugs
  23. Biomineralization-inspired dasatinib nanodrug with sequential infiltration for effective solid tumor treatment
    Yanhong Liu, Lingchao Li, Jiyong Liu, Mengnan Yang, Honglan Wang, Xuxin Chu, Jianping Zhou, Meirong Huo, Tingjie Yin · 2020 · Biomaterials
  24. Flavonoid display ability to target microRNAs in cancer pathogenesis
    Shilpi Singh, Waseem Raza, Shahnaz Parveen, Abha Meena, Suaib Luqman · 2021 · Biochemical Pharmacology
  25. The Biological Process of Aging and the Impact of Ionizing Radiation
    Mohammed Al‐Jumayli, Stephen L. Brown, Indrin J. Chetty, Martine Extermann, Benjamin Movsas · 2022 · Seminars in Radiation Oncology
  26. SPINKs in Tumors: Potential Therapeutic Targets
    Chengcheng Liao, Qian Wang, Jiaxing An, Minglin Zhang, Jie Chen, Xiaolan Li, Linlin Xiao, Jiajia Wang, Qian Long, Jianguo Liu et al. · 2022 · Frontiers in Oncology
  27. Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
    Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques, Laura Wisniewski, Emma Newport, Vinothini Rajeeve, Rebecca J.G. Drake, Jesús Gómez-Escudero, Frances M. Richards et al. · 2022 · Cancer Research
  28. Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance
    Pradip K. De, Jennifer Carlson Aske, Raed A Sulaiman, Nandini Dey · 2022 · Cancers
  29. Antiretroviral protease inhibitors induce features of cellular senescence that are reversible upon drug removal
    Chisaka Kuehnemann, Jun‐Wei B. Hughes, Pierre‐Yves Desprez, Simon Melov, Christopher D. Wiley, Judith Campisi · 2022 · Aging Cell
  30. Effect of Chemotherapeutic Drugs on Caspase-3 Activity, as a Key Biomarker for Apoptosis in Ovarian Tumor Cell Cultured as Monolayer. A Pilot Study.
    Ewa Łucja Gregoraszczuk, Agnieszka Rak, Janusz Ryś, Jerzy Jakubowicz, Krzysztof Urbański · 2015 · Europe PMC (PubMed Central)
  31. Secreted Frizzled Related Protein 2 Modulates Epithelial–Mesenchymal Transition and Stemness via Wnt/β-Catenin Signaling in Choriocarcinoma
    Xianling Zeng, Yafei Zhang, Huiqiu Xu, Taohong Zhang, Yan Xue, Ruifang An · 2018 · Cellular Physiology and Biochemistry
  32. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer
    J. Suzuki, M. Tsuboi, G. Ishii · 2021 · Expert Review of Anticancer Therapy
  33. Curcumin against gastrointestinal cancer: A review of the pharmacological mechanisms underlying its antitumor activity
    Yuanyuan Fan, Xiqin Zhang, Yuxin Tong, Suning Chen, Jingjing Liang · 2022 · Frontiers in Pharmacology
  34. Resolving breast cancer heterogeneity by searching reliable protein cancer biomarkers in the breast fluid secretome
    Ferdinando Mannello, Daniela Ligi · 2013 · BMC Cancer
  35. DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway
    Vishal Kothari, Jonathan F. Goodwin, Shuang George Zhao, Justin M. Drake, Yi Yin, Sei‐Won Laura Chang, Joseph R. Evans, Kari Wilder-Romans, Kristina M. Gabbara, Emanuela Dylgjeri et al. · 2019 · Clinical Cancer Research
  36. Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB–Triggered SASP in Cancer-Associated Fibroblasts
    Ping Jin, Xin Li, Yu Xia, Huayi Li, Xiaoting Li, Zongyuan Yang, Zhen Wang, Cheng Xu, Tian Fang, Dongchen Zhou et al. · 2023 · Molecular Cancer Therapeutics
  37. Unlocking antitumor immunity with adenosine receptor blockers
    Victoria Ann Remley, Joel M Linden, Todd W. Bauer, Julien Dimastromatteo · 2023 · Cancer Drug Resistance
  38. Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma
    Grégory Lazarian, Chloé Friedrich, Anne Quinquenel, Julie Tran, Souhaïl Ouriemmi, Elisabetta Dondi, Antoine Martin, Imane Mihoub, David Chiron, Céline Bellanger et al. · 2020 · Oncogene
  39. Minimal residual disease in advanced or metastatic solid cancers: The G0-G1 state and immunotherapy are key to unwinding cancer complexity
    Andrea Nicolini, Giuseppe Rossi, Paola Ferrari, Angelo Carpi · 2020 · Seminars in Cancer Biology
  40. Endothelial Cells Promote Docetaxel Resistance of Prostate Cancer Cells by Inducing ERG Expression and Activating Akt/mTOR Signaling Pathway
    Wenhao Zhou, Yiming Su, Yu Zhang, Bangmin Han, Haitao Liu, Xiaohai Wang · 2020 · Frontiers in Oncology
  41. Mesenchymal Stem/Stromal Cells May Decrease Success of Cancer Treatment by Inducing Resistance to Chemotherapy in Cancer Cells
    Taja Železnik Ramuta, Mateja Erdani Kreft · 2022 · Cancers
  42. Inosine Released from Dying or Dead Cells Stimulates Cell Proliferation via Adenosine Receptors
    Jin Chen, Ricardo A. Chaurio, Christian Maueröder, Anja Derer, Manfred Rauh, Andriy Kost, Yi Liu, Xianming Mo, Axel J. Hueber, Rostyslav O. Bilyy et al. · 2017 · Frontiers in Immunology
  43. The microenvironment and resistance to personalized cancer therapy
    Shigeo Masuda, Juan Carlos Izpisúa Belmonte · 2012 · Nature Reviews Clinical Oncology
  44. Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer
    J. Silberstein, Maritza N Taylor, E. Antonarakis · 2016 · Current Urology Reports
  45. Cancer Exosomes as Mediators of Drug Resistance
    Maria do Rosário André, Ana Beatriz P. Pedro, David C. Lyden · 2016 · Methods in molecular biology
  46. Downregulated IGFBP7 facilitates liver metastasis by modulating epithelial‑mesenchymal transition in colon cancer
    Yuanfei Li, Yanfeng Xi, Guoqiang Zhu, Junmei Jia, He Huang, Yanyan Liu, Yarong Guo, Lixin Liu · 2019 · Oncology Reports
  47. Anti-Cancer Activity Profiling of Chemotherapeutic Agents in 3D Co-Cultures of Pancreatic Tumor Spheroids with Cancer-Associated Fibroblasts and Macrophages
    So-Dam Jang, Jeeyeun Song, Hyun‐Ah Kim, Chang‐Nim Im, Iftikhar Ali Khawar, Jong Kook Park, Hyo‐Jeong Kuh · 2021 · Cancers
  48. Senotherapies: A novel strategy for synergistic anti-tumor therapy
    Xuxin Qi, Jiang Li, Ji Cao · 2022 · Drug Discovery Today
  49. Senescent Stromal Cells in the Tumor Microenvironment: Victims or Accomplices?
    Minghan Ye, Xinyi Huang, Qianju Wu, Fei Liu · 2023 · Cancers
  50. Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness
    Tamaki Hirano, Reiko Satow, Asami Kato, Mana Tamura, Yumi Murayama, Hideyuki Saya, Hirotatsu Kojima, Tetsuo Nagano, Takayoshi Okabe, Kiyoko Fukami · 2013 · Biochemical Pharmacology
  51. The War on Cancer: Lessons from the War on Terror
    Sui Huang · 2014 · Frontiers in Oncology
  52. Phylostratigraphic analysis of tumor and developmental transcriptomes reveals relationship between oncogenesis, phylogenesis and ontogenesis
    Joseph Zhou, Luis Humberto Cisneros, Theo Knijnenburg, Kalliopi Trachana, P. C. W. Davies, Sui Huang · 2018 · Convergent Science Physical Oncology
  53. Epithelial plasticity in prostate cancer: principles and clinical perspectives
    Rajdeep Das, Philip A. Gregory, Brett G. Hollier, Wayne D. Tilley, Luke A. Selth · 2014 · Trends in Molecular Medicine
  54. Gemcitabine triggers angiogenesis-promoting molecular signals in pancreatic cancer cells: Therapeutic implications
    Mohammad Aslam Khan, Sanjeev K. Srivastava, Arun Bhardwaj, Seema Singh, Sumit Arora, Haseeb Zubair, James E. Carter, Ajay P. Singh · 2015 · Oncotarget
  55. WNT16B from Ovarian Fibroblasts Induces Differentiation of Regulatory T Cells through β-Catenin Signal in Dendritic Cells
    Congcong Shen, Yu‐Huan Kang, Ming Zhao, Yi He, Dandan Cui, Yuyin Fu, Linglin Yang, Lantu Gou · 2014 · International Journal of Molecular Sciences
  56. The host immunological response to cancer therapy: An emerging concept in tumor biology
    Tali Voloshin, Emile E. Voest, Yuval Shaked · 2013 · Experimental Cell Research
  57. Drug repurposing screening identifies bortezomib and panobinostat as drugs targeting cancer associated fibroblasts (CAFs) by synergistic induction of apoptosis
    Hakmin Lee, Eunmyong Lee, So-Young Yeo, Sang Hyun Shin, Hyunkyu Park, Do‐Hyun Nam, Seok‐Hyung Kim · 2018 · Investigational New Drugs
  58. Defeating Cancers’ Adaptive Defensive Strategies Using Thermal Therapies: Examining Cancer’s Therapeutic Resistance, Ablative, and Computational Modeling Strategies as a means for Improving Therapeutic Outcome
    John M. Baust, Yoed Rabin, Thomas James Polascik, Kimberly L. Santucci, Kristi K. Snyder, Robert G. Van Buskirk, John G. Baust · 2018 · Technology in Cancer Research & Treatment
  59. Pan-senescence transcriptome analysis identified RRAD as a marker and negative regulator of cellular senescence
    Zhao Wei, Haiyang Guo, Junchao Qin, Shihua Lu, Qiao Liu, Xiyu Zhang, Yongxin Zou, Yaoqin Gong, Changshun Shao · 2018 · Free Radical Biology and Medicine
  60. Multiple oncogenic roles of nuclear β-catenin
    Raju Kumar, Murali Dharan Bashyam · 2017 · Journal of Biosciences
  61. Activated Wnt/β-Catenin signaling contributes to E3 ubiquitin ligase EDD-conferred docetaxel resistance in prostate cancer
    Pan Bian, Zhongling Dou, Zhaohui Jia, Wensheng Li, Dong Pan · 2019 · Life Sciences
  62. A pHe sensitive nanodrug for collaborative penetration and inhibition of metastatic tumors
    Meirong Huo, Jiyuan Zhou, Honglan Wang, Yuzhao Zheng, Yuqing Tong, Jianping Zhou, Jiyong Liu, Tingjie Yin · 2022 · Journal of Controlled Release
  63. Establishment of cancer-associated fibroblasts-related subtypes and prognostic index for prostate cancer through single-cell and bulk RNA transcriptome
    Youliang Qian, Dechao Feng, Jie Wang, Wuran Wei, Qiang Wei, Ping Han, Lu Yang · 2023 · Scientific Reports
  64. Enhancing chemotherapy for pancreatic cancer through efficient and sustained tumor microenvironment remodeling with a fibroblast-targeted nanosystem
    Xinyuan Zhou, Pan Zhang, Nan Liu, Xiao Zhang, Hui Lv, Wei Xu, Meirong Huo · 2023 · Journal of Controlled Release
  65. Assessment of Ovarian Cancer Tumors Treated with Intraperitoneal Cisplatin Therapy by Nanoscopic X-ray Fluorescence Imaging
    Brecht Laforce, Charlotte Carlier, Bart Vekemans, Julie Villanova, Rémi Tucoulou, Wim P Ceelen, László Vincze · 2016 · Scientific Reports
  66. Senescent cells: A new Achilles’ heel to exploit for cancer medicine?
    Boyi Zhang, Eric W.‐F. Lam, Yu Sun · 2018 · Aging Cell
  67. Where does cellular senescence belong in the pathophysiology of ovarian cancer?
    Krzysztof Książek · 2020 · Seminars in Cancer Biology
  68. Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance
    Ramesh Butti, Ashwini Khaladkar, Priya Bhardwaj, Gopinath Prakasam · 2023 · Cancer Drug Resistance
  69. Metabolism targeting therapy of dichloroacetate-loaded electrospun mats on colorectal cancer
    Daxing Liu, Feifei Wang, Jun Yue, Xiabin Jing, Yubin Huang · 2013 · Drug Delivery
  70. Aiding and Abetting: How the Tumor Microenvironment Protects Cancer from Chemotherapy
    Eleanor C. Fiedler, Michael T. Hemann · 2018 · Annual Review of Cancer Biology
  71. Glucose starvation induces resistance to metformin through the elevation of mitochondrial multidrug resistance protein 1
    Sung‐Hyun Hwang, Myung‐Chul Kim, Sumin Ji, Yeseul Yang, Yeji Jeong, Yongbaek Kim · 2019 · Cancer Science
  72. Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance
    Andrej Panic, Julia Ketteler, Henning Reis, Ali Sak, Carsten Herskind, Patrick Maier, Herbert Rubben, Verena Jendrossek, Diana Klein · 2017 · Scientific Reports
  73. Transforming cancer cells for long-term living with cancer: An inspiring new approach
    Mingjie Jiang, Dian-na Gu, Fu-Rao Liu, Chen-jing Lin, Ling Tian · 2023 · Chinese Journal of Cancer Research
  74. Precision targeted cancer-associated fibroblast nano-regulator enhanced chemo-immunotherapy for triple-negative breast cancer
    Peng Xian, Linghui Zou, Jiaxin Zhang, Xier Pan, Yangjie Song, Yunrong Nan, Qing Pu, Huizhen Liu, Don Green, Shuting Ni et al. · 2025 · Biomaterials
  75. Current Research Status of Metronomic Chemotherapy in Combination Treatment of Breast Cancer
    Jiaxuan Liu, Maiyue He, Zijing Wang, Qiao Li, Binghe Xu · 2022 · Oncology Research and Treatment
  76. Mesoporous nanodrug delivery system: a powerful tool for a new paradigm of remodeling of the tumor microenvironment
    Yinhui Hang, Yanfang Liu, Zhaogang Teng, Xiongfeng Cao, Haitao Zhu · 2023 · Journal of Nanobiotechnology
  77. RETRACTED: LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway
    Binshen Chen, Kai Yuan Xu, Yiming Zhang, Peng Xu, Chaoming Li, Jun Liu, Yawen Xu · 2023 · Cancers · Retracted
  78. Anticancer Drug Discovery — From Serendipity to Rational Design
    Jolanta Natalia Latosińska, Magdalena Latosińska · 2013 · InTech eBooks
  79. Novel Therapies for the Treatment of Advanced Prostate Cancer
    Julie Clarke, Andrew J. Armstrong · 2013 · Current Treatment Options in Oncology
  80. Tumour cells coerce host tissue to cancer spread
    Ilaria Malanchi · 2013 · BoneKEy Reports
  81. Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells
    Yi-Te Lin, Chuck C.‐K. Chao · 2015 · Oncotarget
  82. Clearance of senescent hepatocytes in a neoplastic-prone microenvironment delays the emergence of hepatocellular carcinoma
    Fabio Marongiu, Maria Paola Serra, Marcella Sini, Fabrizio Angius, Ezio Laconi · 2014 · Aging
  83. Review of cancer-associated fibroblasts and their microenvironment in post-chemotherapy recurrence
    Genichiro Ishii, Takahiro Ishii · 2020 · Human Cell
  84. Three-Dimensional Cell Culture Models of Hepatocellular Carcinoma — a Review
    Irmak Ayvaz, Dilara Sunay, Ece Sarıyar, Esra Erdal, Zeynep Fırtına Karagonlar · 2021 · Journal of Gastrointestinal Cancer
  85. Mitofusin 1 silencing decreases the senescent associated secretory phenotype, promotes immune cell recruitment and delays melanoma tumor growth after chemotherapy
    Doménica Tarallo, Jennyfer Martínez, Alejandro Leyva, Amy Mónaco, Carolina Perroni, Marcos R. Tassano, Juan Pablo Gambini, Mónica Cappetta, Rosario Durán, Marı́a Moreno et al. · 2024 · Scientific Reports
  86. Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis
    Chris Hemmings · 2013 · Pathology
  87. Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies?
    Fei Chen, Xinyi Qi, Min Qian, Yue Dai, Yu Sun · 2014 · Protein & Cell
  88. Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy
    Péter Csermely, Tamás Korcsmáros, Ruth Nussinov · 2016 · Seminars in Cell and Developmental Biology
  89. Recent Advances in the Studies of Molecular Mechanisms Regulating Multidrug Resistance in Cancer Cells
    A. A. Stavrovskaya, Ekaterina Yu. Rybalkina · 2018 · Biochemistry (Moscow)
  90. Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells
    Yongfeng He, Erika Hooker, Eun‐Jeong Yu, Gerald R. Cunha, Lan Liao, Jianming Xu, Andrew Earl, Huiqing Wu, Michael L. Gonzalgo, Zijie Sun · 2018 · Oncogene
  91. Photodestruction of Stromal Fibroblasts Enhances Tumor Response to PDT in 3D Pancreatic Cancer Coculture Models
    Vida Karimnia, Imran Rizvi, Frank John Slack, Jonathan P. Celli · 2020 · Photochemistry and Photobiology
  92. WNT-induced association of Frizzled and LRP6 is not sufficient for the initiation of WNT/β-catenin signaling
    Jan Hendrik Voss, Zsombor Kőszegi, Yining Yan, Emily Shorter, Lukas Grätz, Johanna T. Lanner, Davide Calebiro, Gunnar Schulte · 2025 · Nature Communications
  93. Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor–Host Feedback Signaling
    Iris Kamer, Inbal Daniel‐Meshulam, Oranit Zadok, Elizabeta Bab-Dinitz, Gili Perry, Rotem Feniger-Barish, Marina Perelman, Iris Barshack, Alon Ben‐Nun, Amir Onn et al. · 2020 · Molecular Cancer Research
  94. Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence
    Li‐Bin Gao, Ya‐Hong Wang, Zhihua Liu, Yu Sun, Peng Cai, Qing Jing · 2021 · Aging Cell
  95. Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments
    Lennart Kester, Danielle Seinstra, Annelot G.J. van Rossum, Claire Vennin, Marlous Hoogstraat, Daphne van der Velden, Mark Opdam, Erik van Werkhoven, Kerstin Hahn, Iris Nederlof et al. · 2021 · Clinical Cancer Research
  96. Cardiac stem cell aging and heart failure
    Daniela Cesselli, Aneta Aleksova, Elisa Mazzega, Angela Caragnano, Antonio Paolo Beltrami · 2017 · Pharmacological Research
  97. A comparison of prostate cancer cell transcriptomes in 2D monoculture vs 3D xenografts identify consistent gene expression alterations associated with tumor microenvironments
    Lauren Brady, Rui M. Gil da Costa, Ilsa M. Coleman, Clinton K. Matson, Michael Christopher Risk, ROGER T. COLEMAN, Peter S. Nelson · 2020 · The Prostate
  98. Apoptosis in the Pancreatic Cancer Tumor Microenvironment—The Double-Edged Sword of Cancer-Associated Fibroblasts
    Ester Pfeifer, Joy Burchell, Francesco Dazzi, Debashis Sarker, Richard Beatson · 2021 · Cells
  99. Utility of radiomic zones for risk classification and clinical outcome predictions using supervised machine learning during simultaneous 11C‐choline PET/MRI acquisition in prostate cancer patients
    Shu‐Ju Tu, Vuong Thuy Tran, Jian Ming Teo, Wen Chuan Chong, Jing‐Ren Tseng · 2021 · Medical Physics
  100. Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report.
    Giuseppe Di Bella, Fabrizio Mascia, Alessandro Ricchi, Biagio Colori · 2013 · PubMed